These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 5354663)

  • 1. [Trial of treatment of E male G 2 leukemia by a combination of chemotherapy and specific and non-specific immunotherapy].
    Amiel JL; Bérardet M
    Rev Fr Etud Clin Biol; 1969; 14(7):685-8. PubMed ID: 5354663
    [No Abstract]   [Full Text] [Related]  

  • 2. Non-leukaemic AkR mice are not tolerant to cells of leukaemia induced by Gross virus.
    Doré JF; Ajuria E; Mathé G
    Rev Eur Etud Clin Biol; 1970 Jan; 15(1):81-4. PubMed ID: 5442690
    [No Abstract]   [Full Text] [Related]  

  • 3. [BCG and experimental leukemia].
    Amiel JL; Berardet M
    Ann Inst Pasteur (Paris); 1972 Apr; 122(4):701-14. PubMed ID: 4559236
    [No Abstract]   [Full Text] [Related]  

  • 4. Active immunotherapy of AkR mice spontaneous leukemia.
    Mathé G; Halle-Pannenko O; Bourut C
    Rev Eur Etud Clin Biol; 1972 Dec; 17(10):997-1000. PubMed ID: 4660002
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of treatment with a combination of 6-mercaptopurine and porfiromycin on an established Friend leukemia virus infection.
    Sidwell RW; Dixon GJ; Compton P; Schabel FM
    Cancer Res; 1969 Mar; 29(3):497-502. PubMed ID: 5773795
    [No Abstract]   [Full Text] [Related]  

  • 6. [Non specific active immunotherapy by B.C.G. in virus induced leukemia in E male G2 mice in isogenic receiptients].
    Amiel JL
    Rev Fr Etud Clin Biol; 1967 Nov; 12(9):912-4. PubMed ID: 5591341
    [No Abstract]   [Full Text] [Related]  

  • 7. [Induction of immune insufficiency in adult mice by the additive utilization of a non-specific stimulant of immune reactions and of immunosuppressive chemotherapy].
    Amiel JL; Bérardet M
    Rev Fr Etud Clin Biol; 1969 Nov; 14(9):912-5. PubMed ID: 5365729
    [No Abstract]   [Full Text] [Related]  

  • 8. [Use of BCG as an immunoadjuvant in combination with antitumor agents in virus-induced leukemia].
    Sbaraglia G; Cenci E; Vecchiarelli A; Perito S
    Boll Soc Ital Biol Sper; 1980 Oct; 56(19):1969-75. PubMed ID: 7459108
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of active specific and non-specific immunotherapy on E male G2 leukemia according to the route of administration and combination of immunological stimulants.
    Amiel JL; Bĕrardet M
    Eur J Cancer (1965); 1971 Oct; 7(5):419-23. PubMed ID: 5159873
    [No Abstract]   [Full Text] [Related]  

  • 10. Development of resistance to MOPC-315 plasmacytoma after intralesional and intraperitoneal melphalan therapy of tumor-bearing BALB/c mice. I. Enhancement of in vivo rejection responses by combined chemotherapy-immunotherapy.
    Adler A; Altbaum I
    J Natl Cancer Inst; 1982 Jun; 68(6):963-9. PubMed ID: 6953275
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BCG protection of mice challenged with virulent Yersinia enterocolitica.
    Santos Filho L; Ricciard ID; Pinto Gontijo Filho P
    Rev Latinoam Microbiol; 1982; 24(1):11-3. PubMed ID: 7186672
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of BCG (Romanian substrain) on the Ehrlich carcinoma in A2G mice.
    Piţur I; Ciufecu E; Drăghici D; Andronescu F; Glăvan D
    Arch Roum Pathol Exp Microbiol; 1979; 38(1):95-103. PubMed ID: 546376
    [No Abstract]   [Full Text] [Related]  

  • 13. [Attempts at active non-specific immunotherapy using formolized Corynebacterium parvum].
    Amiel JL; Litwin J; Bérardet M
    Rev Fr Etud Clin Biol; 1969 Nov; 14(9):909-12. PubMed ID: 5365728
    [No Abstract]   [Full Text] [Related]  

  • 14. Studies on heterologous antilymphocyte and antithymocyte sera. II. Effects on cellular antibody production during the early primary and secondary immune response of mice to sheep erythrocytes.
    Barth RF; Southworth J
    J Immunol; 1968 Dec; 101(6):1283-90. PubMed ID: 5722464
    [No Abstract]   [Full Text] [Related]  

  • 15. Histopathologic and humoral study of Balb/c mice inoculated with BCG by different routes.
    Acosta A; Sarmiento ME; González A; Estévez P; Aguila A; Infante JF; Izquierdo L; Capó V; Sierra G; Malberty JA
    Arch Med Res; 1994; 25(2):159-63. PubMed ID: 7919805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Letter: Routes other than I.V. injection to mice for BCG administration in active immunotherapy of L1210 leukemia.
    Martin M; Bourut C; Halle-Pannenko O; Mathé
    Biomedicine; 1975 Oct; 23(8):339-40. PubMed ID: 1231929
    [No Abstract]   [Full Text] [Related]  

  • 17. [Experimental study of the antineoplastic activity of the antibiotic reumycin].
    Navashin SM; Fomina IP; Koroleva VG; Terent'eva TG; Shtegal'man LA
    Antibiotiki; 1967 Oct; 12(10):892-8. PubMed ID: 5631328
    [No Abstract]   [Full Text] [Related]  

  • 18. Studies on cytophilic antibodies. II. The production by guinea-pigs of macrophage cytophilic antibodies to sheep erythrocytes and human serum albumin: relationship to the production of other antibodies and the development of delayed-type hypersensitivity.
    Nelson DS; Mildenhall P
    Aust J Exp Biol Med Sci; 1968 Feb; 46(1):33-49. PubMed ID: 5650356
    [No Abstract]   [Full Text] [Related]  

  • 19. The influence of vaccination on the course of experimental airborne tuberculosis in mice.
    Schell RF; Ealey WF; Harding GE; Smith DW
    J Reticuloendothel Soc; 1974 Sep; 16(3):131-8. PubMed ID: 4455899
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunotherapy of murine tumor with syngeneic antitumor serum plus BCG.
    Yamazaki M; Saito M; Abe S; Mizuno D
    Jpn J Exp Med; 1983 Feb; 53(1):27-32. PubMed ID: 6876475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.